Abstract
Cardiovascular diseases (CVD) are the leading cause of mortality in the world. Despite the advances achieved in the pharmacological and surgical aspects, little progress has been obtained towards prevention. Among the alternatives to reduce CVD risk, the intake of omega 3 fatty acids (n3FA) supplements, in especial the eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has shown …